Whole Exome Analysis of NIAAA Clinical Center pATIENTS
Health and Human Services, Department of · NATIONAL INSTITUTES OF HEALTH
This notice is not accepting responses (deadline was Jul 1, 2026, 8:00 PM EDT).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Jul 1, 2026, 8:00 PM EDT
- Posted
- Jun 21, 2026
- Solicitation
- 75N98026Q00677
- Set-aside
- No Set aside used
- Place of performance
- Bethesda, MD, USA
- Contracting office
- NATIONAL INSTITUTES OF HEALTH OLAO · BETHESDA · MD
- Source
- SAM.gov · updated Jun 22, 2026
Description
The NIAAA Clinical Center patient cohort has been analyzed patients for sequence variant differences, and changes in response to treatment over the course of many years as part of an effort to identify underlying causes of alcohol related disorders. Analysis has previously been performed on over 2000 patients using the AmpliSeq Exome enrichment system and sequenced on the ION sequencing platform because it provides the capability of cost-effective high throughput whole-exome genome-wide analysis. The use of a single enrichment and sequencing platform with consistent information content is essential for analysis of samples screened at different times and it is therefore imperative for analytical integrity that all samples in the study are processed on the same sequencing platform, as each platform has a unique pattern of error
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$30,580
Middle of the pack for similar past awards
Most similar awards fall between $16,237 and $293,313
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1DYNPORT VACCINE COMPANY LLC1 award$235.12M
- 2SEQIRUS INC9 awards$74.97M
- 3GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC.1 award$72.77M
- 4GLAXOSMITHKLINE, LLC5 awards$30.69M
- 5SANOFI VACCINES US INC.6 awards$23.95M
- 6BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC5 awards$10.18M
- 7SEQIRUS USA INC5 awards$9.22M
- 8ARTEMIS TECHNOLOGIES INC3 awards$8.03M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID aa04d360a0034c6cbe4e2bae2a6f17c2.